Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients

被引:15
|
作者
Parra-Bonilla, G
Arboleda, G
Yunis, J
Solano, E
Pardo, R
Arango, G
Hedmont, D
Arboleda, H
机构
[1] Univ Nacl Colombia, Inst Genet, Bogota, Colombia
[2] Univ Manchester, Sch Biol Sci, Manchester, Lancs, England
[3] Univ Nacl Colombia, Fac Med, Bogota, Colombia
[4] Univ Nacl Colombia, Fac Med, Dept Neurol, Bogota, Colombia
[5] Univ Nacl Colombia, Fac Med, Bogota, Colombia
关键词
Alzheimer's disease; APOE promoter polymorphisms; haplogroups; Colombian population;
D O I
10.1016/S0304-3940(03)00816-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Results analyzing the association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease (AD) are contradictory. We studied the association of three polymorphisms in the APOE promoter (-219T/G, -491A/T and -427T/C) with AD in a sample of the Colombian population. The polymorphism -491A/T confers increased risk for AD associated with AA genotype independent of APOEe4 allele (odds ratio (OR): 2.64) and more pronounced in men (OR: 6.07). Genotypes TT and TG of -219T/G showed a significant association with AD, but this was lost in an adjusted model. We did not find any association with -427T/C polymorphism. Using a haplogroup analysis of the promoter polymorphisins, we further confirmed their independent contribution as genetic risk factors for AD. (C) 2003 Published by Elsevier Ireland Ltd.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [1] Apolipoprotein E promoter polymorphisms (−491A/T and −427T/C) and Alzheimer’s disease: no evidence of association in the Irish population
    C. A. Lynch
    J. Brazil
    B. Cullen
    D. Coakley
    M. Gill
    B. A. Lawlor
    Z. Hawi
    [J]. Irish Journal of Medical Science, 2008, 177 : 29 - 33
  • [2] The APOE promoter polymorphisms-219 T/G and-491 A/T in a sample of Alzheimer's disease patients from Colombia
    Parra, G
    Arboleda, H
    Yunis, JJ
    Camelo, D
    Pardo, R
    Solano, E
    Arango, G
    Hedmont, D
    Arboleda, GH
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S338 - S338
  • [3] Apolipoprotein E promoter polymorphisms (-491A/T and-427T/C) and Alzheimer's disease: no evidence of association in the Irish population
    Lynch, C. A.
    Brazil, J.
    Cullen, B.
    Coakley, D.
    Gill, M.
    Lawlor, B. A.
    Hawi, Z.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2008, 177 (01) : 29 - 33
  • [4] Promoter polymorphism (–491A/T) in the APOE gene of Finnish Alzheimer’s disease patients and control individuals
    S. Helisalmi
    Mikko Hiltunen
    Piia Valonen
    Arto Mannermaa
    Anne Maria Koivisto
    Maarit Lehtovirta
    Markku Ryynänen
    Hilkka Soininen
    [J]. Journal of Neurology, 1999, 246 : 821 - 824
  • [5] Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals
    Helisalmi, S
    Hiltunen, M
    Valonen, P
    Mannermaa, A
    Koivisto, AM
    Lehtovirta, M
    Ryynänen, M
    Soininen, H
    [J]. JOURNAL OF NEUROLOGY, 1999, 246 (09) : 821 - 824
  • [6] Association between ε2/3/4, Promoter Polymorphism (-491A/T,-427T/C, and-219T/G) at the Apolipoprotein E Gene, and Mental Retardation in Children from an Iodine Deficiency Area, China
    Li, Jun
    Zhang, Fuchang
    Wang, Yunliang
    Wang, Yan
    Qin, Wei
    Xing, Qinghe
    Qian, Xueqing
    Guo, Tingwei
    Gao, Xiaocai
    He, Lin
    Gao, Jianjun
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] ApoE −491A/T Promoter Polymorphism is not an Independent Risk Factor, but Associated with the ε4 Allele in Hungarian Alzheimer’s Dementia Population
    Anna Juhász
    András Palotás
    Zoltán Janka
    Ágnes Rimanóczy
    Miklós Palotás
    Nikoletta Bódi
    Krisztina Boda
    Marianna Zana
    Gábor Vincze
    János Kálmán
    [J]. Neurochemical Research, 2005, 30 : 591 - 596
  • [8] The -491A/T polymorphism of the apolipoprotein E gene is associated with the ApoEε4 allele and Alzheimer's Disease
    Ahmed, ARH
    MacGowan, SH
    Culpan, D
    Jones, RW
    Wilcock, GK
    [J]. NEUROSCIENCE LETTERS, 1999, 263 (2-3) : 217 - 219
  • [9] The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism
    Town, T
    Paris, D
    Fallin, D
    Duara, R
    Barker, W
    Gold, M
    Crawford, F
    Mullan, M
    [J]. NEUROSCIENCE LETTERS, 1998, 252 (02) : 95 - 98
  • [10] APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample
    Choi, Kyu Yeong
    Lee, Jang Jae
    Gunasekaran, Tamil Iniyan
    Kang, Sarang
    Lee, Wooje
    Jeong, Jangho
    Lim, Ho Jae
    Zhang, Xiaoling
    Zhu, Congcong
    Won, So-Yoon
    Choi, Yu Yong
    Seo, Eun Hyun
    Lee, Seok Cheol
    Gim, Jungsoo
    Chung, Ji Yeon
    Chong, Ari
    Byun, Min Soo
    Seo, Sujin
    Ko, Pan-Woo
    Han, Ji-Won
    McLean, Catriona
    Farrell, John
    Lunetta, Kathryn L.
    Miyashita, Akinori
    Hara, Norikazu
    Won, Sungho
    Choi, Seong-Min
    Ha, Jung-Min
    Jeong, Jee Hyang
    Kuwano, Ryozo
    Song, Min Kyung
    An, Seong Soo A.
    Lee, Young Min
    Park, Kyung Won
    Lee, Ho-Won
    Choi, Seong Hye
    Rhee, Sangmyung
    Song, Woo Keun
    Lee, Jung Sup
    Mayeux, Richard
    Haines, Jonathan L.
    Pericak-Vance, Margaret A.
    Choo, Il Han
    Nho, Kwangsik
    Kim, Ki-Woong
    Lee, Dong Young
    Kim, SangYun
    Kim, Byeong C.
    Kim, Hoowon
    Jun, Gyungah R.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)